Literature DB >> 1632072

Immunophysiological studies of interleukin-2 and canine lymphocytes.

S C Helfand1, J F Modiano, P C Nowell.   

Abstract

Interleukin-2-dependent pathways of lymphocyte activation were investigated in canine peripheral blood lymphocytes (PBL) following stimulation with T-cell mitogens including phytohemagglutinin, phorbol ester (TPA), calcium ionophore (ionomycin), and human recombinant interleukin-2 (hrIL-2). The ability of the stimulated cells to produce interleukin-2 (IL-2) was determined using murine indicator cell lines. IL-2 receptor expression by mitogen-stimulated canine PBL was confirmed by the binding of hrIL-2 with high affinity, and with characteristics comparable to those of the human and murine IL-2 receptor. Examination of serum and PBL from two dogs that were treated with hrIL-2 and human recombinant tumor necrosis factor for systemic mast cell tumors showed that in one dog, IL-2 could be measured in the serum. Concurrently, the in vitro mitogenic response of this dog's PBL to hrIL-2 occurred earlier, possibly reflecting an increase in the relative number of IL-2-responsive cells within the PBL population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632072     DOI: 10.1016/0165-2427(92)90030-t

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs.

Authors:  S C Helfand; S A Soergel; P S MacWilliams; J A Hank; P M Sondel
Journal:  Cancer Immunol Immunother       Date:  1994-08       Impact factor: 6.968

Review 2.  Manipulation of Innate Immunity for Cancer Therapy in Dogs.

Authors:  Daniel Regan; Steven Dow
Journal:  Vet Sci       Date:  2015-12-01

3.  T-cell activation and early gene response in dogs.

Authors:  Sally-Anne Mortlock; Jerry Wei; Peter Williamson
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

4.  A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.

Authors:  Sara E Fritz; Michael S Henson; Emily Greengard; Amber L Winter; Kathleen M Stuebner; Una Yoon; Vicki L Wilk; Antonella Borgatti; Lance B Augustin; Jaime F Modiano; Daniel A Saltzman
Journal:  Vet Med Sci       Date:  2016-06-06

5.  Stimulation with Concanavalin-A Induces IL-17 Production by Canine Peripheral T Cells.

Authors:  Michelle G Ritt; Beth A Lindborg; Timothy D O'Brien; Joseph Bisignano; Jaime F Modiano
Journal:  Vet Sci       Date:  2015-04-10

6.  Requirement of dual stimulation by homologous recombinant IL-2 and recombinant IL-12 for the in vitro production of interferon gamma by canine peripheral blood mononuclear cells.

Authors:  Andrea Mendes Pereira; Cristiane Garboggini Melo de Pinheiro; Lenita Ramires Dos Santos; Naiara Carvalho Teixeira; Yung-Fu Chang; Lain Carlos Pontes-de-Carvalho; Geraldo Gileno de Sá Oliveira
Journal:  BMC Res Notes       Date:  2014-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.